Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.02 Billion SAR | 5.02% |
| 2022 | 3.83 Billion SAR | -13.58% |
| 2021 | 4.43 Billion SAR | -5.31% |
| 2020 | 4.68 Billion SAR | 1.27% |
| 2019 | 4.62 Billion SAR | -3.01% |
| 2018 | 4.76 Billion SAR | -0.05% |
| 2017 | 4.77 Billion SAR | -1.44% |
| 2016 | 4.83 Billion SAR | 26.55% |
| 2015 | 3.82 Billion SAR | -7.98% |
| 2014 | 4.15 Billion SAR | -4.88% |
| 2013 | 4.36 Billion SAR | 19.75% |
| 2012 | 3.64 Billion SAR | -2.4% |
| 2011 | 3.73 Billion SAR | 8.18% |
| 2010 | 3.45 Billion SAR | 26.93% |
| 2009 | 2.72 Billion SAR | 40.55% |
| 2008 | 1.93 Billion SAR | -42.3% |
| 2007 | 3.35 Billion SAR | 39.74% |
| 2006 | 2.4 Billion SAR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.35 Billion SAR | 8.25% |
| 2024 Q2 | 4.41 Billion SAR | 1.3% |
| 2023 Q3 | 4.13 Billion SAR | -1.79% |
| 2023 Q2 | 4.2 Billion SAR | -0.62% |
| 2023 Q1 | 4.23 Billion SAR | 10.46% |
| 2023 Q4 | 4.02 Billion SAR | -2.6% |
| 2023 FY | 4.02 Billion SAR | 5.02% |
| 2022 Q4 | 3.83 Billion SAR | -8.87% |
| 2022 FY | 3.83 Billion SAR | -13.58% |
| 2022 Q1 | 4.53 Billion SAR | 2.39% |
| 2022 Q2 | 4.53 Billion SAR | -0.0% |
| 2022 Q3 | 4.2 Billion SAR | -7.38% |
| 2021 Q1 | 4.71 Billion SAR | 0.6% |
| 2021 FY | 4.43 Billion SAR | -5.31% |
| 2021 Q3 | 4.6 Billion SAR | -0.0% |
| 2021 Q4 | 4.43 Billion SAR | -3.64% |
| 2021 Q2 | 4.6 Billion SAR | -2.32% |
| 2020 Q4 | 4.68 Billion SAR | -1.45% |
| 2020 FY | 4.68 Billion SAR | 1.27% |
| 2020 Q2 | 4.75 Billion SAR | 6.49% |
| 2020 Q3 | 4.75 Billion SAR | -0.1% |
| 2020 Q1 | 4.46 Billion SAR | -3.39% |
| 2019 Q1 | 5.05 Billion SAR | 5.93% |
| 2019 FY | 4.62 Billion SAR | -3.01% |
| 2019 Q4 | 4.62 Billion SAR | -9.28% |
| 2019 Q3 | 5.09 Billion SAR | -1.76% |
| 2019 Q2 | 5.18 Billion SAR | 2.73% |
| 2018 Q1 | 5.12 Billion SAR | 7.42% |
| 2018 FY | 4.76 Billion SAR | -0.05% |
| 2018 Q2 | 8.45 Billion SAR | 65.07% |
| 2018 Q3 | 5.16 Billion SAR | -38.93% |
| 2018 Q4 | 4.76 Billion SAR | -7.7% |
| 2017 Q3 | 4.71 Billion SAR | 2.62% |
| 2017 Q1 | 4.73 Billion SAR | -2.21% |
| 2017 FY | 4.77 Billion SAR | -1.44% |
| 2017 Q4 | 4.77 Billion SAR | 1.24% |
| 2017 Q2 | 4.59 Billion SAR | -2.99% |
| 2016 Q3 | 4.84 Billion SAR | 4.63% |
| 2016 Q2 | 4.63 Billion SAR | 8.46% |
| 2016 Q1 | 4.27 Billion SAR | 11.66% |
| 2016 FY | 4.83 Billion SAR | 26.55% |
| 2016 Q4 | 4.83 Billion SAR | -0.12% |
| 2015 Q3 | 3.97 Billion SAR | -8.93% |
| 2015 FY | 3.82 Billion SAR | -7.98% |
| 2015 Q4 | 3.82 Billion SAR | -3.76% |
| 2015 Q2 | 4.36 Billion SAR | 5.31% |
| 2015 Q1 | 4.14 Billion SAR | -0.3% |
| 2014 FY | 4.15 Billion SAR | -4.88% |
| 2014 Q4 | 4.15 Billion SAR | -14.59% |
| 2014 Q3 | 4.86 Billion SAR | 6.86% |
| 2014 Q2 | 4.55 Billion SAR | -0.25% |
| 2014 Q1 | 4.56 Billion SAR | 4.48% |
| 2013 Q4 | 4.36 Billion SAR | 8.38% |
| 2013 FY | 4.36 Billion SAR | 19.75% |
| 2013 Q1 | 3.84 Billion SAR | 5.31% |
| 2013 Q2 | 3.89 Billion SAR | 1.38% |
| 2013 Q3 | 4.03 Billion SAR | 3.51% |
| 2012 Q4 | 3.64 Billion SAR | -2.37% |
| 2012 FY | 3.64 Billion SAR | -2.4% |
| 2012 Q3 | 3.73 Billion SAR | 0.0% |
| 2011 FY | 3.73 Billion SAR | 8.18% |
| 2010 FY | 3.45 Billion SAR | 26.93% |
| 2009 FY | 2.72 Billion SAR | 40.55% |
| 2008 FY | 1.93 Billion SAR | -42.3% |
| 2007 FY | 3.35 Billion SAR | 39.74% |
| 2006 FY | 2.4 Billion SAR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 1.65 Billion SAR | -143.265% |